<td class= Dadun
   (New user)
Help  | Contact  |  Castellano English  

Dadun > Depósito Académico > CIFA (Centro de Investigación en Farmacobiología Aplicada) > Unidad de I+D de Medicamentos > DA - CIFA - I+D de medicamentos - Artículos de revistas >

New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.
Authors: Ancizu, S. (Saioa)
Castrillo, N. (Nerea)
Perez-Silanes, S. (Silvia)
Aldana, I. (Ignacio)
Monge, A. (Antonio)
Delagrange, P. (Philippe)
Caignard, D.H. (Daniel-Henry)
Galiano, S. (Silvia)
Keywords: Sleep disorders
MT1/MT2 receptors
Issue Date: 2012
Publisher: MDPI
Publisher version:
ISSN: 1420-3049
Citation: Ancizu S, Castrillo N, Perez-Silanes S, Aldana I, Monge A, Delagrange P, et al. New quinoxaline derivatives as potential MT(1) and MT(2) receptor ligands. Molecules 2012 Jun 25;17(7):7737-7757.
Ever since the idea arose that melatonin might promote sleep and resynchronize circadian rhythms, many research groups have centered their efforts on obtaining new melatonin receptor ligands whose pharmacophores include an aliphatic chain of variable length united to an N-alkylamide and a methoxy group (or a bioisostere), linked to a central ring. Substitution of the indole ring found in melatonin with a naphthalene or quinoline ring leads to compounds of similar affinity. The next step in this structural approximation is to introduce a quinoxaline ring (a bioisostere of the quinoline and naphthalene rings) as the central nucleus of future melatoninergic ligands
Permanent link:
Appears in Collections:DA - Farmacia - Orgánica - Artículos de revista
DA - CIFA - I+D de medicamentos - Artículos de revistas

Files in This Item:
File:  MOL12.pdf
Size:  494,98 kB
Format:  Adobe PDF
 View / Open 

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.